Hubei Zhenhua Chemical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	4,680	4,505	4,054	3,686	3,494	2,956
Other Revenue	30.58	30.58	12.73	12.85	39.96	36.99
Revenue	4,710	4,536	4,067	3,699	3,534	2,993
Revenue Growth (YoY)	13.81%	11.53%	9.95%	4.67%	18.06%	134.13%
Cost of Revenue	3,483	3,359	3,054	2,802	2,588	2,252
Gross Profit	1,227	1,177	1,012	896.32	945.58	740.81
Selling, General & Admin	384.83	359.63	295.05	297.44	289.78	249.87
Research & Development	138.56	147.34	128.35	114.61	106.32	82.74
Other Operating Expenses	16.08	7.4	0.86	23.04	27.69	23.71
Operating Expenses	554.36	529.24	429.33	435.62	424.21	354.43
Operating Income	672.73	647.55	582.92	460.69	521.37	386.39
Interest Expense	-42.67	-42.67	-36.92	-35.27	-33.79	-36.87
Interest & Investment Income	3.36	7.37	3.68	5.05	5.58	4.05
Currency Exchange Gain (Loss)	0.7	0.7	5.69	1.26	8.5	-0.26
Other Non Operating Income (Expenses)	143.76	151.71	-1.99	-0.83	-0.84	-11.49
EBT Excluding Unusual Items	778.04	764.65	553.38	430.9	500.82	341.81
Impairment of Goodwill	-3.56	-3.56	-	-1.28	-	-
Gain (Loss) on Sale of Investments	-9.87	-12.42	-9.92	-8.36	-19.75	-2.04
Gain (Loss) on Sale of Assets	-17.99	-17.94	-8.32	-14.78	-5.79	-0.35
Asset Writedown	-2.49	0.05	0.3	0.02	0.06	-5.16
Other Unusual Items	12.51	12.51	5.57	8.02	8.15	-
Pretax Income	756.64	743.3	541.02	414.52	483.49	334.26
Income Tax Expense	94.98	86.85	69.28	42.16	59.8	22.43
Earnings From Continuing Operations	661.66	656.45	471.74	372.36	423.69	311.83
Minority Interest in Earnings	1.61	2.59	1.14	-1.55	-6.71	-1.16
Net Income	663.27	659.04	472.88	370.81	416.97	310.67
Net Income to Common	663.27	659.04	472.88	370.81	416.97	310.67
Net Income Growth	31.41%	39.37%	27.53%	-11.07%	34.22%	107.34%
Shares Outstanding (Basic)	715	709	706	701	703	690
Shares Outstanding (Diluted)	747	740	716	711	712	690
Shares Change (YoY)	3.22%	3.35%	0.74%	-0.10%	3.12%	15.19%
EPS (Basic)	0.93	0.93	0.67	0.53	0.59	0.45
EPS (Diluted)	0.89	0.89	0.66	0.52	0.59	0.45
EPS Growth	27.31%	34.85%	26.58%	-10.98%	30.16%	80.00%
Free Cash Flow	-191.61	-81.04	49.12	103.65	230.66	78.27
Free Cash Flow Per Share	-0.26	-0.11	0.07	0.15	0.32	0.11
Dividend Per Share	0.160	0.160	0.136	0.131	0.148	0.131
Dividend Growth	17.91%	17.91%	3.83%	-11.63%	12.56%	100.00%
Gross Margin	26.05%	25.95%	24.89%	24.23%	26.76%	24.75%
Operating Margin	14.28%	14.28%	14.33%	12.46%	14.75%	12.91%
Profit Margin	14.08%	14.53%	11.63%	10.03%	11.80%	10.38%
Free Cash Flow Margin	-4.07%	-1.79%	1.21%	2.80%	6.53%	2.61%
EBITDA	925.93	891.16	788.15	655.29	709.8	551.17
EBITDA Margin	19.66%	19.65%	19.38%	17.72%	20.09%	18.41%
D&A For EBITDA	253.21	243.61	205.23	194.6	188.42	164.79
EBIT	672.73	647.55	582.92	460.69	521.37	386.39
EBIT Margin	14.28%	14.28%	14.33%	12.46%	14.75%	12.91%
Effective Tax Rate	12.55%	11.68%	12.80%	10.17%	12.37%	6.71%
Revenue as Reported	4,536	4,536	4,067	3,699	3,534	-
Advertising Expenses	-	2.06	1.92	1.7	0.49	0.6

Source: S&P Global Market Intelligence. Standard template. Financial Sources.